ECM
OMED

Endurant Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Endurant Capital Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-219,114
Closed -$465K – 83
2018
Q3 		$465K Buy
+219,114
New +$465K 0.21% 63
2018
Q1 		– Sell
-139,100
Closed -$570K – 91
2017
Q4 		$570K Buy
+139,100
New +$570K 0.17% 69